Improvement of the Surveillance and Control of Liver Disease and Complication Due to Chronic Hepatitis C: Project A) Antiviral Drugs Use, Efficacy, Safety and Costs; Project B) Kinetics of Virological Response.
(Project B) To evaluate the viral kinetic decay during antiviral combination therapy with
P-IFN alfa-2a and 2b type plus ribavirin.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Evaluation of real dose drugs intake in relation to sustained virological response (SVR).
Project A) The analysis will describe the efficacy (SVR) and costs of the 3 different antiviral schedules proposed.
Measurement of HCV-RNA at 24° week after therapy withdrawal.
No
liliana chemello, M.D., Ph.D.
Study Chair
University of Padua
Italy: Ethics Committee
HEPCOVE protocol
NCT01195181
September 2005
August 2010
Name | Location |
---|